ID   KCRM_RAT                Reviewed;         381 AA.
AC   P00564; Q6P6R9;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   24-JUL-2024, entry version 156.
DE   RecName: Full=Creatine kinase M-type;
DE            EC=2.7.3.2 {ECO:0000250|UniProtKB:P00563};
DE   AltName: Full=Creatine kinase M chain;
DE   AltName: Full=Creatine phosphokinase M-type;
DE            Short=CPK-M;
DE   AltName: Full=M-CK;
GN   Name=Ckm; Synonyms=Ckmm;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   STRAIN=Fischer 344;
RX   PubMed=6209281; DOI=10.1016/s0021-9258(17)42700-1;
RA   Benfield P.A., Zivin R.A., Miller L.S., Sowder R., Smythers G.W.,
RA   Henderson L., Oroszlan S., Pearson M.L.;
RT   "Isolation and sequence analysis of cDNA clones coding for rat skeletal
RT   muscle creatine kinase.";
RL   J. Biol. Chem. 259:14979-14984(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 87-381.
RA   Benfield P.A., Zivin R.A., Shearman C.W., Graf D., Henderson L.,
RA   Oroszlan S., Pearson M.L.;
RT   "The nucleotide sequence of rat muscle creatine kinase cDNA and ckm
RT   transcription during myogenesis in an RNA polymerase II mutant of L6
RT   myoblasts.";
RL   Exp. Biol. Med. 9:187-194(1984).
RN   [4]
RP   PROTEIN SEQUENCE OF 87-96; 139-148; 157-170 AND 321-341, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Spinal cord;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (DEC-2006) to UniProtKB.
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-166; SER-178; THR-180;
RP   SER-199; THR-313; THR-322 AND SER-372, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Reversibly catalyzes the transfer of phosphate between ATP
CC       and various phosphogens (e.g. creatine phosphate). Creatine kinase
CC       isoenzymes play a central role in energy transduction in tissues with
CC       large, fluctuating energy demands, such as skeletal muscle, heart,
CC       brain and spermatozoa. {ECO:0000250|UniProtKB:P00563}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + creatine = ADP + H(+) + N-phosphocreatine;
CC         Xref=Rhea:RHEA:17157, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:57947, ChEBI:CHEBI:58092, ChEBI:CHEBI:456216; EC=2.7.3.2;
CC         Evidence={ECO:0000250|UniProtKB:P00563, ECO:0000255|PROSITE-
CC         ProRule:PRU10029};
CC   -!- SUBUNIT: Dimer of identical or non-identical chains, which can be
CC       either B (brain type) or M (muscle type). With MM being the major form
CC       in skeletal muscle and myocardium, MB existing in myocardium, and BB
CC       existing in many tissues, especially brain.
CC       {ECO:0000250|UniProtKB:P12277}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- SIMILARITY: Belongs to the ATP:guanido phosphotransferase family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00842, ECO:0000255|PROSITE-
CC       ProRule:PRU00843}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M10140; AAA40935.1; -; mRNA.
DR   EMBL; BC062058; AAH62058.1; -; mRNA.
DR   EMBL; M14864; AAA40936.1; -; mRNA.
DR   PIR; A00674; KIRTCM.
DR   RefSeq; NP_036662.1; NM_012530.2.
DR   AlphaFoldDB; P00564; -.
DR   SMR; P00564; -.
DR   BioGRID; 246449; 3.
DR   IntAct; P00564; 1.
DR   MINT; P00564; -.
DR   STRING; 10116.ENSRNOP00000022895; -.
DR   ChEMBL; CHEMBL2176800; -.
DR   GlyGen; P00564; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P00564; -.
DR   PhosphoSitePlus; P00564; -.
DR   SwissPalm; P00564; -.
DR   jPOST; P00564; -.
DR   PaxDb; 10116-ENSRNOP00000022895; -.
DR   GeneID; 24265; -.
DR   KEGG; rno:24265; -.
DR   UCSC; RGD:2358; rat.
DR   AGR; RGD:2358; -.
DR   CTD; 1158; -.
DR   RGD; 2358; Ckm.
DR   eggNOG; KOG3581; Eukaryota.
DR   InParanoid; P00564; -.
DR   OrthoDB; 35839at2759; -.
DR   PhylomeDB; P00564; -.
DR   TreeFam; TF314214; -.
DR   Reactome; R-RNO-71288; Creatine metabolism.
DR   PRO; PR:P00564; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005615; C:extracellular space; ISS:AgBase.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004111; F:creatine kinase activity; IDA:RGD.
DR   GO; GO:0046314; P:phosphocreatine biosynthetic process; IDA:RGD.
DR   GO; GO:0009408; P:response to heat; ISS:AgBase.
DR   CDD; cd00716; creatine_kinase_like; 1.
DR   Gene3D; 1.10.135.10; ATP:guanido phosphotransferase, N-terminal domain; 1.
DR   Gene3D; 3.30.590.10; Glutamine synthetase/guanido kinase, catalytic domain; 1.
DR   InterPro; IPR000749; ATP-guanido_PTrfase.
DR   InterPro; IPR022415; ATP-guanido_PTrfase_AS.
DR   InterPro; IPR022414; ATP-guanido_PTrfase_cat.
DR   InterPro; IPR022413; ATP-guanido_PTrfase_N.
DR   InterPro; IPR036802; ATP-guanido_PTrfase_N_sf.
DR   InterPro; IPR014746; Gln_synth/guanido_kin_cat_dom.
DR   PANTHER; PTHR11547; ARGININE OR CREATINE KINASE; 1.
DR   PANTHER; PTHR11547:SF63; CREATINE KINASE M-TYPE; 1.
DR   Pfam; PF00217; ATP-gua_Ptrans; 1.
DR   Pfam; PF02807; ATP-gua_PtransN; 1.
DR   SUPFAM; SSF55931; Glutamine synthetase/guanido kinase; 1.
DR   SUPFAM; SSF48034; Guanido kinase N-terminal domain; 1.
DR   PROSITE; PS00112; PHOSPHAGEN_KINASE; 1.
DR   PROSITE; PS51510; PHOSPHAGEN_KINASE_C; 1.
DR   PROSITE; PS51509; PHOSPHAGEN_KINASE_N; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cytoplasm; Direct protein sequencing; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Transferase.
FT   CHAIN           1..381
FT                   /note="Creatine kinase M-type"
FT                   /id="PRO_0000211979"
FT   DOMAIN          11..98
FT                   /note="Phosphagen kinase N-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00842"
FT   DOMAIN          125..367
FT                   /note="Phosphagen kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00843"
FT   BINDING         128..132
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00843"
FT   BINDING         191
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00843"
FT   BINDING         236
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00843"
FT   BINDING         292
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00843"
FT   BINDING         320..325
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00843"
FT   BINDING         335
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00843"
FT   MOD_RES         164
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P07310"
FT   MOD_RES         166
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         178
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         180
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         199
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         313
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         322
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         372
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CONFLICT        16
FT                   /note="P -> S (in Ref. 1; AAA40935)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        87
FT                   /note="D -> N (in Ref. 3; AAA40936)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        100
FT                   /note="Y -> F (in Ref. 1; AAA40935 and 3; AAA40936)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   381 AA;  43045 MW;  B573FEB1D2A41056 CRC64;
     MPFGNTHNKF KLNYKPQEEY PDLSKHNNHM AKVLTPDLYN KLRDKETPSG FTLDDVIQTG
     VDNPGHPFIM TVGCVAGDEE SYTVFKDLFD PIIQDRHGGY KPTDKHKTDL NHENLKGGDD
     LDPNYVLSSR VRTGRSIKGY TLPPHCSRGE RRAVEKLSVE ALNSLTGEFK GKYYPLKSMT
     EQEQQQLIDD HFLFDKPVSP LLLASGMARD WPDARGIWHN DNKSFLVWVN EEDHLRVISM
     EKGGNMKEVF RRFCVGLQKI EEIFKKAGHP FMWNEHLGYV LTCPSNLGTG LRGGVHVKLA
     NLSKHPKFEE ILTRLRLQKR GTGGVDTAAV GAVFDISNAD RLGSSEVEQV QLVVDGVKLM
     VEMEKKLEKG QSIDDMIPAQ K
//
